Search Results

There are 8426 results for: content related to: Pharmacokinetics of pioglitazone after multiple oral dose administration in horses

  1. Pioglitazone for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Bernd Richter, Elizabeth Bandeira-Echtler, Karla Bergerhoff, Christine Clar and Susanne H Ebrahim

    Published Online : 18 OCT 2006, DOI: 10.1002/14651858.CD006060.pub2

  2. You have free access to this content
    Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 11, November 2013, Pages: 967–977, A. Consoli and G. Formoso

    Version of Record online : 18 APR 2013, DOI: 10.1111/dom.12101

  3. You have free access to this content
    Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis

    British Journal of Clinical Pharmacology

    Volume 78, Issue 2, August 2014, Pages: 258–273, Richard M. Turner, Chun S. Kwok, Chen Chen-Turner, Chinedu A. Maduakor, Sonal Singh and Yoon K. Loke

    Version of Record online : 21 JUL 2014, DOI: 10.1111/bcp.12306

  4. The role of pioglitazone in modifying the atherogenic lipoprotein profile

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 8, August 2009, Pages: 742–756, M. Hanefeld

    Version of Record online : 10 JUN 2009, DOI: 10.1111/j.1463-1326.2009.01048.x

  5. Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit

    Diabetic Medicine

    Volume 32, Issue 3, March 2015, Pages: 305–313, R. E. J. Ryder

    Version of Record online : 3 DEC 2014, DOI: 10.1111/dme.12627

  6. Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 12, December 2013, Pages: 1101–1110, M. Alba, B. Ahrén, S. E. Inzucchi, Y. Guan, M. Mallick, L. Xu, E. A. O'Neill, D. E. Williams-Herman, K. D. Kaufman and B. J. Goldstein

    Version of Record online : 18 JUL 2013, DOI: 10.1111/dom.12145

  7. Beneficial effects of pioglitazone against cardiovascular injury are enhanced by combination with aliskiren in a rat model of diabetic nephropathy

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 6, June 2012, Pages: 862–871, Rania A. Elrashidy, Mervat E. Asker and Hoda E. Mohamed

    Version of Record online : 29 MAR 2012, DOI: 10.1111/j.2042-7158.2012.01508.x

  8. Earlier triple therapy with pioglitazone in patients with type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 9, September 2009, Pages: 844–854, G. Charpentier, S. Halimi and on behalf of the F-PIO-100 Study Investigators

    Version of Record online : 13 JUL 2009, DOI: 10.1111/j.1463-1326.2009.01055.x

  9. Residual effect of reductions in red blood cell count and haematocrit and haemoglobin levels after 10-month withdrawal of pioglitazone in patients with Type 2 diabetes

    Diabetic Medicine

    Volume 31, Issue 11, November 2014, Pages: 1341–1349, K.-D. Lin, M.-Y. Lee, C.-C. Feng, B. K. Chen, M.-L. Yu and S.-J. Shin

    Version of Record online : 30 MAY 2014, DOI: 10.1111/dme.12481

  10. Observational follow-up of the PROactive study: a 6-year update

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 1, January 2014, Pages: 63–74, E. Erdmann, E. Song, R. Spanheimer, A.-R. van Troostenburg de Bruyn and A. Perez

    Version of Record online : 19 AUG 2013, DOI: 10.1111/dom.12180

  11. Effects of pioglitazone on lipid and lipoprotein metabolism

    Diabetes, Obesity and Metabolism

    Volume 9, Issue 5, September 2007, Pages: 640–647, D. John Betteridge

    Version of Record online : 26 FEB 2007, DOI: 10.1111/j.1463-1326.2007.00715.x

  12. You have free access to this content
    Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function

    British Journal of Pharmacology

    Volume 166, Issue 4, June 2012, Pages: 1303–1319, Raquel Hernanz, Ángela Martín, Jose V Pérez-Girón, Roberto Palacios, Ana M Briones, Marta Miguel, Mercedes Salaices and María J Alonso

    Version of Record online : 17 MAY 2012, DOI: 10.1111/j.1476-5381.2012.01825.x

  13. Pioglitazone attenuates fatty acid–induced oxidative stress and apoptosis in pancreatic β-cells

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 7, July 2008, Pages: 564–573, Y. Saitoh, C. Chun-ping, K. Noma, H. Ueno, M. Mizuta and M. Nakazato

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1463-1326.2007.00749.x

  14. Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 12, December 2008, Pages: 1221–1238, E. Mannucci, M. Monami, C. Lamanna, G. F. Gensini and N. Marchionni

    Version of Record online : 26 MAY 2008, DOI: 10.1111/j.1463-1326.2008.00892.x

  15. Efficacy and safety of initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes: a 54-week study

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 8, August 2012, Pages: 745–752, K. H. Yoon, H. Steinberg, R. Teng, G. T. Golm, M. Lee, E. A. O'Neill, K. D. Kaufman and B. J. Goldstein

    Version of Record online : 17 APR 2012, DOI: 10.1111/j.1463-1326.2012.01594.x

  16. Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: Role of nitric oxide

    Clinical and Experimental Pharmacology and Physiology

    Volume 41, Issue 2, February 2014, Pages: 118–126, Pedram Paragomi, Reza Rahimian, Mohammad Hossein Kazemi, Mohammad Hadi Gharedaghi, Amin Khalifeh-Soltani, Saeedeh Azary, Abbas Norouzi Javidan, Kamran Moradi, Stephen Sakuma and Ahmad Reza Dehpour

    Version of Record online : 28 JAN 2014, DOI: 10.1111/1440-1681.12188

  17. PIOGLITAZONE INHIBITS HOMOCYSTEINE-INDUCED MIGRATION OF VASCULAR SMOOTH MUSCLE CELLS THROUGH A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ-INDEPENDENT MECHANISM

    Clinical and Experimental Pharmacology and Physiology

    Volume 35, Issue 12, December 2008, Pages: 1471–1476, Li Li, Ping-Jin Gao, Rui Xi, Chun-Fang Wu, Ding-Liang Zhu, Jing Yan and Guo-Ping Lu

    Version of Record online : 28 AUG 2008, DOI: 10.1111/j.1440-1681.2008.05025.x

  18. PPAR-γ Activator Pioglitazone Prevents Age-Related Atrial Fibrillation Susceptibility by Improving Antioxidant Capacity and Reducing Apoptosis in a Rat Model

    Journal of Cardiovascular Electrophysiology

    Volume 23, Issue 2, February 2012, Pages: 209–217, DONGZHU XU, NOBUYUKI MURAKOSHI, MIYAKO IGARASHI, AKI HIRAYAMA, YOKO ITO, YOSHIHIRO SEO, HIROSHI TADA and KAZUTAKA AONUMA

    Version of Record online : 28 SEP 2011, DOI: 10.1111/j.1540-8167.2011.02186.x

  19. You have free access to this content
    Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-Ay mice

    Hepatology

    Volume 49, Issue 5, May 2009, Pages: 1636–1644, Tomonori Aoyama, Kenichi Ikejima, Kazuyoshi Kon, Kyoko Okumura, Kumiko Arai and Sumio Watanabe

    Version of Record online : 9 FEB 2009, DOI: 10.1002/hep.22828

  20. Effects of Gemfibrozil, Itraconazole, and Their Combination on the Pharmacokinetics of Pioglitazone

    Clinical Pharmacology & Therapeutics

    Volume 77, Issue 5, May 2005, Pages: 404–414, Tiina Jaakkola, Janne T. Backman, Mikko Neuvonen and Pertti J. Neuvonen

    Version of Record online : 16 MAY 2005, DOI: 10.1016/j.clpt.2004.12.266